{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:10:18Z","timestamp":1785769818893,"version":"3.56.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,10]]},"abstract":"<jats:sec>\n                    <jats:title>\u00a0<\/jats:title>\n                    <jats:p>\n                      We aimed to compare maternal serum prostasin levels between women with early-onset preeclampsia (PE) and healthy pregnant controls to establish pathophysiological differences. We also sought to evaluate the diagnostic performance of maternal serum prostasin as a potential biomarker for early-onset PE, including determination of optimal cutoff values for clinical application. This was a prospective case\u2013control study including 43 pregnant women who were diagnosed with early-onset PE between 20\n                      <jats:sup>0\/7<\/jats:sup>\n                      to 34\n                      <jats:sup>0\/7<\/jats:sup>\n                      weeks of gestation from March to September 2022. Also, 45 healthy pregnant women were included in the control group. Demographic characteristics, complete blood count and biochemical parameters, and serum prostasin concentrations were documented. A receiver operating characteristic curve was generated to demonstrate the sensitivity and specificity of prostasin, and the optimal cutoff value was determined using the Youden index. The median maternal serum prostasin level was found to be significantly higher in the early-onset PE group (31.66 [27.12\u201351.00] ng\/mL) compared to the control group (22.33 [16.03\u201325.89] ng\/mL) with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value &lt;.001. The area under the curve was found to be 0.820\u2005\u00b1\u20050.047 (95% CI: 0.729\u20130.912), indicating a statistically significant discriminative ability (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). The optimal cutoff value for maternal serum prostasin level was determined using the Youden index, with a threshold of \u226526.44\u2009ng\/mL corresponding to a sensitivity of 0.837 and a specificity of 0.778 for the diagnosis of early-onset PE. Based on the multivariate model results, a maternal serum prostasin value of &gt;26.44\u2009ng\/mL increases the risk of early-onset PE by approximately 20-fold. Maternal serum prostasin levels are significantly elevated in early-onset preeclamptic mothers compared to the healthy controls. These findings suggest that prostasin may play a role in early-onset PE pathophysiology and could serve as a biomarker for its diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048323","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:02:07Z","timestamp":1775840527000},"page":"e48323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative and diagnostic evaluation of maternal serum prostasin in early-onset preeclampsia"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-6806","authenticated-orcid":false,"given":"G\u00f6khan","family":"Bolluk","sequence":"first","affiliation":[{"name":"Department of Perinatology, Health Sciences University, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7634-3008","authenticated-orcid":false,"given":"S\u00fcleyman Cemil","family":"O\u011flak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Health Sciences University, Gazi Ya\u015fargil Training and Research Hospital, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-7675","authenticated-orcid":false,"given":"Zeynep","family":"Kayao\u011flu Yildirim","sequence":"additional","affiliation":[{"name":"Department of Perinatology, Health Sciences University, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-5235","authenticated-orcid":false,"given":"O\u011fuzhan","family":"Zengi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Health Sciences University, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2016.12.002","article-title":"Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia.","volume":"7","author":"Yucel","year":"2017","journal-title":"Pregnancy Hypertens"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jch.14254","article-title":"Prevalence of hypertensive disorders during pregnancy in France (2010\u20132018): the Nationwide CONCEPTION Study.","volume":"23","author":"Olie","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"605","DOI":"10.16899\/jcm.945345","article-title":"The expression of angiogenic protein Cyr61 significantly increases in the urine of early-onset preeclampsia patients.","volume":"11","author":"Behram","year":"2021","journal-title":"J Contemp Med"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21613\/GORM.2023.1469","article-title":"Placental vimentin expression in preeclampsia and gestational diabetes mellitus.","volume":"30","author":"Asir","year":"2024","journal-title":"Gynecol Obstet Reprod Med"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"867","DOI":"10.24953\/turkjped.2021.05.014","article-title":"The possible association between neonatal morbidities and amniotic fluid pH and electrolyte levels in infants of preeclamptic mothers.","volume":"63","author":"Semerci","year":"2021","journal-title":"Turk J Pediatr"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"2478577","DOI":"10.1080\/01443615.2025.2478577","article-title":"Immunohistochemical and bioinformatics analysis of the placental BCL-2 and Beclin-1 expressions in preeclampsia and HELLP syndrome.","volume":"45","author":"O\u011flak","year":"2025","journal-title":"J Obstet Gynaecol"},{"key":"R7-20260410","first-page":"219","article-title":"WIPI-2 protein expression increases in the placentas of patients with preeclampsia.","volume":"31","author":"A\u015fir","year":"2023","journal-title":"Perinatal J"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of key innate immune cells in early- and late-onset preeclampsia.","volume":"11","author":"Aneman","year":"2020","journal-title":"Front Immunol"},{"key":"R9-20260410","doi-asserted-by":"crossref","first-page":"946433","DOI":"10.3389\/fcvm.2022.946433","article-title":"Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia.","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jog.15129","article-title":"Increased maternal serum aquaporin-9 expression in pregnancies complicated with early-onset preeclampsia.","volume":"48","author":"\u00d6lmez","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00424-014-1661-5","article-title":"Urinary serine proteases and activation of ENaC in kidney \u2013 implications for physiological renal salt handling and hypertensive disorders with albuminuria.","volume":"467","author":"Svenningsen","year":"2015","journal-title":"Pflugers Arch"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/hr.2012.232","article-title":"Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium.","volume":"36","author":"Olivieri","year":"2013","journal-title":"Hypertens Res"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humrep\/dep457","article-title":"Prostasin regulates human placental trophoblast cell proliferation via the epidermal growth factor receptor signaling pathway.","volume":"25","author":"Fu","year":"2010","journal-title":"Hum Reprod"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jp.2014.136","article-title":"Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion.","volume":"35","author":"Yang","year":"2015","journal-title":"J Perinatol"},{"key":"R15-20260410","first-page":"1","article-title":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.preghy.2011.10.001","article-title":"Plasma soluble corin and N-terminal pro-atrial natriuretic peptide levels in pregnancy induced hypertension.","volume":"2","author":"Zaki","year":"2012","journal-title":"Pregnancy Hypertens"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/HJH.0000000000000795","article-title":"Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.","volume":"34","author":"Frederiksen-Moller","year":"2016","journal-title":"J Hypertens"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"12728","DOI":"10.3390\/ijms241612728","article-title":"Activation of the renin\u2013angiotensin\u2013aldosterone system is attenuated in hypertensive compared with normotensive pregnancy.","volume":"24","author":"Shoemaker","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"902634","DOI":"10.3389\/fmed.2022.902634","article-title":"Maternal low volume circulation relates to normotensive and preeclamptic fetal growth restriction.","volume":"9","author":"Gyselaers","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/HJH.0000000000000828","article-title":"Prostasin, proteases, and preeclampsia.","volume":"34","author":"Small","year":"2016","journal-title":"J Hypertens"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"e1002937","DOI":"10.1371\/journal.pgen.1002937","article-title":"Reduced prostasin (CAP1\/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.","volume":"8","author":"Szabo","year":"2012","journal-title":"PLoS Genet"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20110097","article-title":"Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.","volume":"122","author":"Verlohren","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/hr.2014.31","article-title":"A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19\u201331 weeks of gestation.","volume":"37","author":"Hirashima","year":"2014","journal-title":"Hypertens Res"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000359968","article-title":"Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30\u201333 weeks\u2019 gestation.","volume":"35","author":"Lai","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.ASN.0000043900.39397.48","article-title":"Inhibition of prostasin secretion by serine protease inhibitors in the kidney.","volume":"14","author":"Iwashita","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:21:58Z","timestamp":1785766918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":25,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048323","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2025-02-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}